George Goldberger

George S. Goldberger is the Founder and Chief Executive Officer of Cell One Partners, a company he established in 2018 and began operating in 2019.1 With a rich background in the cell and gene therapy industry, Goldberger has made significant contributions to the field throughout his career.

Professional Background

Cell and Gene Therapy Experience:

Prior to founding Cell One Partners, Goldberger co-founded Progenitor Cell Therapy (PCT) in 1998, which later became known as Minaris Regenerative Medicine.1 As one of the earliest cell and gene therapy contract development and manufacturing organizations, PCT grew into a global leader under Goldberger's leadership. During his tenure at PCT, he served as chief financial and business officer and later as chief development officer.1

International Business Experience:

Goldberger's career also includes international business experience. He was previously the president and CEO of Goldberger & Associates, Inc., a global management consulting firm with offices in New York, Bucharest, and Kiev.1 In this role, he advised U.S. and European companies on developing businesses in various Eastern European countries.

Education

Goldberger holds an MBA in finance and international business from the Wharton School of Business at the University of Pennsylvania.1 He also has a BS in systems engineering from the New York University Tandon School of Engineering.1

Current Role

At Cell One Partners, Goldberger continues to be active in the cell and gene therapy industry. He frequently shares insights and perspectives on the global cell and gene therapy market through presentations and LinkedIn posts.23

George Goldberger's extensive experience in the cell and gene therapy sector, combined with his international business acumen, positions him as a respected figure in the industry. His leadership at Cell One Partners reflects his ongoing commitment to advancing the field of regenerative medicine.